Published in Women's Health Weekly, June 20th, 2002
Following data presented in December at a major breast cancer conference, the American Society of Clinical Oncology (ASCO) convened a blue ribbon panel to review the use of aromatase inhibitors.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly